The 20 Best Head and Neck Squamous Cell Carcinoma (HNSCC) Doctors Near Me in Ann Arbor, MI

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Paul Swiecicki is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Swiecicki is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Squamous Cell Carcinoma. Dr. Swiecicki is board certified in Medical Oncology.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

Scott Mclean is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Tissue Biopsy, and Laryngectomy. Dr. Mclean is board certified in Otolaryngology-Head & Neck Surgery.

Keith Casper is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Casper is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Casper is board certified in Otolaryngology-Head & Neck Surgery.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

Douglas Chepeha is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Chepeha is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Glossectomy, and Laryngectomy.

Avraham Eisbruch is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Eisbruch is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Dry Mouth, Head and Neck Squamous Cell Carcinoma (HNSCC), and Glossectomy.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

"Dr. Michael J. Davis is a Clinical Assistant Professor and board-certified Mohs surgeon and dermatologist in the Michigan Medicine Department of Dermatology. He provides expert care for patients with high-risk and advanced skin cancer in the Cutaneous Surgery and Oncology outpatient clinic at the UM Rogel Cancer Center and is a member of the multidisciplinary cutaneous oncology program.Dr. Davis graduated from the School of Medicine at Emory University, completed a dermatology residency at Dartmouth University, and pursued a Micrographic Surgery and Dermatologic Oncology clinical fellowship at Scripps Health in La Jolla, California. He completed a one-year Cutaneous Oncology Research Fellowship at Memorial Sloan Kettering Cancer Center, where he also served as an instructor of dermatology and interim assistant director of the Mohs lab for the Dermatology Service.Dr. Davis’s clinical and scholarly interests center on cutaneous surgery and oncology, with an emphasis on Mohs histopathology. He has co-authored seven chapters for the ""Laboratory Manual for Mohs Micrographic Surgery Frozen Tissue Processing,"" a comprehensive reference on the Mohs tissue processing technique (Springer, April 2024). He is an active member of the American Academy of Dermatology, the American Society for Dermatologic Surgery, the American College of Mohs Surgery, and the International Immunosuppression and Transplant Skin Cancer Collaborative.". Dr. Davis is rated as an Experienced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Davis is board certified in Micrographic Dermatologic Surgery and Dermatology.

Timothy Johnson is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Merkel Cell Carcinoma.

A Craig is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Craig is rated as an Experienced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.

Dr. Chaz Stucken is an associate professor of otolaryngology- head & neck surgery at the University of Michigan. He is dual-fellowship trained in both head & neck cancer surgery as well as facial plastic & reconstructive surgery. Dr. Stucken completed an accelerated 7-year B.A./M.D. at Boston University, earning his M.D. in 2008. He subsequently completed his training in otolaryngology-head & neck surgery at The Mount Sinai Hospital in New York City, where he received the Chairman’s Award at the completion of residency. Dr. Stucken then earned sub-specialty fellowship training in head & neck oncologic & microvascular surgery at the University of Michigan and in Facial Plastic & Reconstructive Surgery at Ohio State University. Throughout his training, Dr. Stucken received awards for excellence in research and clinical care. He has published several book chapters and scholarly articles in otolaryngology texts and peer-reviewed journals. Dr. Stucken is involved in humanitarian outreach work and has traveled to Guatemala to perform cleft lip surgery. He is dedicated to serving Spanish-speaking patients in southeast Michigan. He has given numerous presentations at conferences around the country, taught at instructional courses for other surgeons, and has been an invited faculty member to symposium on facial plastic & reconstructive surgery. He is an active member of the American Academy of Otolaryngology- Head & Neck Surgery and the American Academy of Facial Plastic & Reconstructive Surgery. He serves on several national committees including the Plastic & Reconstructive Surgery Committee, Microvascular Surgery Committee, and Humanitarian Efforts Committee.Dr. Stucken is committed to providing the highest level of care to his patients. He is also working to discover medical and surgical breakthroughs by collaborating with other surgeons and researchers throughout the medical center. He works closely with cutaneous oncology surgeons to provide optimal skin cancer treatments and reconstruction. As a member of the Comprehensive Head & Neck Cancer Team, he works closely with medical oncologists and radiation oncologists and enrolls patients in the most advanced clinical trials. Surgically, his subspecialty training gives him the opportunity to provide specialized care for every patient in order to obtain the best possible outcomes. Dr. Stucken is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Melanoma, Laryngectomy, and Tissue Biopsy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Facial Plastic & Recon Surg.

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.

Molly Neal is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Neal is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Glossectomy, and Laryngectomy.

Marisa Buchakjian is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Buchakjian is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Tongue Cancer, Throat Cancer, Laryngeal Cancer, Laryngectomy, and Tissue Biopsy. Dr. Buchakjian is board certified in Otolaryngology-Head & Neck Surgery.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Advanced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.